Werewolf Therapeutics (HOWL)
(Delayed Data from NSDQ)
$1.49 USD
+0.04 (2.76%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.47 -0.02 (-1.34%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
HOWL 1.49 +0.04(2.76%)
Will HOWL be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for HOWL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HOWL
Werewolf Therapeutics, Inc. (HOWL) Just Flashed Golden Cross Signal: Do You Buy?
XOMA Royalty (XOMA) Q2 Earnings and Revenues Surpass Estimates
HOWL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Beyond Air, Inc. (XAIR) Reports Q1 Loss, Lags Revenue Estimates
CorMedix (CRMD) Surpasses Q2 Earnings and Revenue Estimates
Werewolf Therapeutics (HOWL) Upgraded to Buy: Here's What You Should Know
Other News for HOWL
180 Bullish Setup appears for HOWL after 2.76% move
Is HOWL building bullish momentum? Pocket Pivot shows up after advancing 3.57%
Bollinger Band Squeeze appears for HOWL after 3.45% move
H.C. Wainwright Sticks to Its Buy Rating for Werewolf Therapeutics (HOWL)
HOWL forms 180 Bullish Setup on September 16